Recommendations to enhance pediatric cardiovascular drug development: Report of a multi-stakeholder think tank

Rachel D. Torok, Jennifer S. Li, Prince J. Kannankeril, Andrew M. Atz, Raafat Bishai, Ellen Bolotin, Stefanie Breitenstein, Cathy Chen, Thomas Diacovo, Timothy Feltes, Patricia Furlong, Michael Hanna, Eric M. Graham, Daphne Hsu, D. Dunbar Ivy, Dianne Murphy, Lisa A. Kammerman, Gregory Kearns, John Lawrence, Brigitte LebeautDanshi Li, Christoph Male, Brian McCrindle, Pierre Mugnier, Jane W. Newburger, Gail D. Pearson, Vasum Peiris, Lisa Percival, Miriam Pina, Ronald Portman, Robert Shaddy, Norman L. Stockbridge, Robert Temple, Kevin D. Hill

Research output: Contribution to journalArticle

10 Scopus citations
Original languageEnglish (US)
Article numbere007283
JournalJournal of the American Heart Association
Volume7
Issue number4
DOIs
StatePublished - Feb 1 2018

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Torok, R. D., Li, J. S., Kannankeril, P. J., Atz, A. M., Bishai, R., Bolotin, E., Breitenstein, S., Chen, C., Diacovo, T., Feltes, T., Furlong, P., Hanna, M., Graham, E. M., Hsu, D., Dunbar Ivy, D., Murphy, D., Kammerman, L. A., Kearns, G., Lawrence, J., ... Hill, K. D. (2018). Recommendations to enhance pediatric cardiovascular drug development: Report of a multi-stakeholder think tank. Journal of the American Heart Association, 7(4), [e007283]. https://doi.org/10.1161/JAHA.117.007283